Have a personal or library account? Click to login
Heterotopic ossification: radiological and pathological review Cover

Heterotopic ossification: radiological and pathological review

Open Access
|Sep 2019

References

  1. Naraghi FF, DeCoster TA, Moneim MS, Miller RA, Rivero D. Heterotopic ossification. Orthopedics 1996; 19: 145-51.
  2. Kornhaber R, Foster N, Edgar D, Visentin D, Ofir E, Haik J, et al. The development and impact of heterotopic ossification in burns: a review of four decades of research. Scars Burn Heal 2017; 3: 2059513117695659. doi: 10.1177/2059513117695659
  3. Cholok D, Chung MT, Ranganathan K, Ucer S, Day D, Davis TA, et al. Heterotopic ossification and the elucidation of pathologic differentiation. Bone 2018; 109: 12-21. doi: 10.1016/j.bone.2017.09.019
  4. Bedi A, Zbeda RM, Bueno VF, Downie B, Dolan M, Kelly BT. The incidence of heterotopic ossification after hip arthroscopy. Am J Sports Med 2012; 40: 854-63. doi: 10.1177/0363546511434285
  5. Cipriano CA, Pill SG, Keenan MA. Heterotopic ossification following traumatic brain injury and spinal cord injury. J Am Acad Orthop Surg 2009; 17: 689-97. doi: 10.5435/00124635-200911000-00003
  6. Medina A, Shankowsky H, Savaryn B, Shukalak B, Tredget EE. Characterization of heterotopic ossification in burn patients. J Burn Care Res 2014; 35: 251-6. doi: 10.1097/BCR.0b013e3182957768
  7. Forsberg JA, Pepek JM, Wagner S, Wilson K, Flint J, Andersen RC, et al. Heterotopic ossification in high-energy wartime extremity injuries: prevalence and risk factors. J Bone Joint Surg Am 2009; 91: 1084-91. doi: 10.2106/JBJS.H.00792
  8. Potter BK, Forsberg JA, Davis TA, Evans KN, Hawksworth JS, Tadaki D, et al. Heterotopic ossification following combat-related trauma. J Bone Joint Surg Am 2010; 92 (Suppl 2): 74-89. doi: 10.2106/JBJS.J.00776
  9. Brooker AF, Bowerman JW, Robinson RA, Riley LH, Jr. Ectopic ossification following total hip replacement. Incidence and a method of classification. J Bone Joint Surg Am 1973; 55: 1629-32.
  10. Shin JJ, de Sa DL, Burnham JM, Mauro CS. Refractory pain following hip arthroscopy: evaluation and management. J Hip Preserv Surg 2018; 5: 3-14. doi: 10.1093/jhps/hnx047
  11. Popovic M, Agarwal A, Zhang L, Yip C, Kreder HJ, Nousiainen MT, et al. Radiotherapy for the prophylaxis of heterotopic ossification: A systematic review and meta-analysis of published data. Radiother Oncol 2014; 113: 10-7. doi: 10.1016/j.radonc.2014.08.025
  12. Pignolo RJ, Bedford-Gay C, Liljesthrom M, Durbin-Johnson BP, Shore EM, Rocke DM, et al. The natural history of flare-ups in fibrodysplasia ossificans progressiva (FOP): A comprehensive global assessment. J Bone Miner Res 2016; 31: 650-6. doi: 10.1002/jbmr.2728
  13. Orchard GR, Paratz JD, Blot S, Roberts JA. Risk factors in hospitalized patients with burn injuries for developing heterotopic ossification- A retrospective analysis. J Burn Care Res 2015; 36: 465-70. doi: 10.1097/ BCR.0000000000000123
  14. Jackson WM, Aragon AB, Onodera J, Koehler SM, Ji Y, Bulken-Hoover JD, et al. Cytokine expression in muscle following traumatic injury. J Orthop Res. 2011; 29: 1613-20. doi: 10.1002/jor.21354
  15. Baird EO, Kang QK. Prophylaxis of heterotopic ossification - an updated review. J Orthop Surg Res 2009; 4: 12. doi: 10.1186/1749-799X-4-12
  16. Wosczyna MN, Biswas AA, Cogswell CA, Goldhamer DJ. Multipotent progenitors resident in the skeletal muscle interstitium exhibit robust BMP-dependent osteogenic activity and mediate heterotopic ossification. J Bone Miner Res 2012; 27: 1004-17. doi: 10.1002/jbmr.1562
  17. Cairns DM, Liu R, Sen M, Canner JP, Schindeler A, Little DG, et al. Interplay of Nkx3.2, Sox9 and Pax3 regulates chondrogenic differentiation of muscle progenitor cells. PloS one 2012; 7: e39642-e. doi: 10.1371/journal. pone.0039642
  18. Lounev VY, Ramachandran R, Wosczyna MN, Yamamoto M, Maidment AD, Shore EM, et al. Identification of progenitor cells that contribute to heterotopic skeletogenesis. J Bone Joint Surg Am 2009; 91: 652-63. doi: 10.2106/ JBJS.H.01177
  19. Zhang X, Jie S, Liu T, Zhang X. Acquired heterotopic ossification in hips and knees following encephalitis: case report and literature review. BMC Surg 2014; 14: 74. doi: 10.1186/1471-2482-14-74
  20. Chalmers J, Gray DH, Rush J. Observations on the induction of bone in soft tissues. J Bone Joint Surg Br 1975; 57: 36-45.
  21. Shimono K, Uchibe K, Kuboki T, Iwamoto M. The pathophysiology of heterotopic ossification: current treatment considerations in dentistry. Jpn Dent Sci Rev 2014; 50: 1-8. doi: 10.1016/j.jdsr.2013.07.003
  22. Bidner SM, Rubins IM, Desjardins JV, Zukor DJ, Goltzman D. Evidence for a humoral mechanism for enhanced osteogenesis after head injury. J Bone Joint Surg Am 1990; 72: 1144-9.
  23. Salisbury E, Rodenberg E, Sonnet C, Hipp J, Gannon FH, Vadakkan TJ, et al. Sensory nerve induced inflammation contributes to heterotopic ossification. J Cell Biochem 2011; 112: 2748-58. doi: 10.1002/jcb.23225
  24. Kan L, Kitterman JA, Procissi D, Chakkalakal S, Peng C-Y, McGuire TL, et al. CNS demyelination in fibrodysplasia ossificans progressiva. J Neurol 2012; 259: 2644-55. doi: 10.1007/s00415-012-6563-x
  25. Shehab D, Elgazzar AH, Collier BD. Heterotopic ossification. J Nucl Med 2002; 43: 346-53.
  26. Rossier AB, Bussat P, Infante F, Zender R, Courvoisier B, Muhelm G, et al. Current facts of para-osteo-arthropathy (POA). Paraplegia 1973; 11: 38-78. doi: 10.1038/sc.1973.5
  27. Wharton GW, Morgan TH. Ankylosis in the paralyzed patient. J Bone Joint Surg Am 1970; 52: 105-12.
  28. Freed JH, Hahn H, Menter R, Dillon T. The use of the three-phase bone scan in the early diagnosis of heterotopic ossification (HO) and in the evaluation of Didronel therapy. Paraplegia 1982; 20: 208-16. doi: 10.1038/sc.1982.39
  29. Zagarella A, Impellizzeri E, Maiolino R, Attolini R, Castoldi MC. Pelvic heterotopic ossification: when CT comes to the aid of MR imaging. Insights Imaging 2013; 4: 595-603. doi: 10.1007/s13244-013-0265-5
  30. Svircev JN, Wallbom AS. False-negative triple-phase bone scans in spinal cord injury to detect clinically suspect heterotopic ossification: a case series. J Spinal Cord Med 2008; 31: 194-6. doi: 10.1080/10790268.2008.11760711
  31. Schurch B, Capaul M, Vallotton MB, Rossier AB. Prostaglandin E2 measurements: their value in the early diagnosis of heterotopic ossification in spinal cord injury patients. Arch Phys Med Rehabil 1997; 78: 687-91. doi: 10.1016/S0003-9993(97)90074-5
  32. Orzel JA, Rudd TG. Heterotopic bone formation: clinical, laboratory, and imaging correlation. J Nucl Med 1985; 26: 125-32.
  33. Daniel Shawn Moore MCEFSC, MD, MBA. Heterotopic Ossification Imaging: Medscape.; 2015 [updated Nov 01, 2015] Available from: https://emedicine.medscape.com/article/390416-overview
  34. Lacout A, Jarraya M, Marcy P-Y, Thariat J, Carlier RY. Myositis ossificans imaging: keys to successful diagnosis. Indian J Radiol Imaging 2012; 22: 35-9. doi: 10.4103/0971-3026.95402
  35. Kransdorf MJ, Meis JM, Jelinek JS. Myositis ossificans: MR appearance with radiologic-pathologic correlation. AJR Am J Roentgenol 1991; 157: 1243-8. doi: 10.2214/ajr.157.6.1950874
  36. De Smet AA, Norris MA, Fisher DR. Magnetic resonance imaging of myositis ossificans: analysis of seven cases. Skeletal Radiol 1992; 21: 503-7. doi: 10.1007/BF00195231
  37. Shirkhoda A, Armin AR, Bis KG, Makris J, Irwin RB, Shetty AN. MR imaging of myositis ossificans: variable patterns at different stages. J Magn Reson Imaging 1995; 5: 287-92. doi: 10.1002/jmri.1880050312
  38. Parikh J, Hyare H, Saifuddin A. The imaging features of post-traumatic myositis ossificans, with emphasis on MRI. Clin Radiol 2002; 57: 1058-66. doi: 10.1053/crad.2002.1120
  39. Ledermann HP, Schweitzer ME, Morrison WB. Pelvic heterotopic ossification: MR imaging characteristics. Radiology 2002; 222: 189-95. doi: 10.1148/radiol.2221010552
  40. Choi YH, Kim KE, Lim SH, Lim JY. Early presentation of heterotopic ossification mimicking pyomyositis - two case reports. Ann Rehabil Med 2012; 36: 713-8. doi: 10.5535/arm.2012.36.5.713
  41. Siegel MJ. Magnetic resonance imaging of musculoskeletal soft tissue masses. Radiol Clin North Am 2001; 39: 701-20. doi: 10.1016/S0033-8389(05)70306-7
  42. Chan WP. Magnetic resonance imaging of soft-tissue tumors of the extremities: A practical approach. World J Radiol 2013; 5: 455-9. doi: 10.4329/wjr. v5.i12.455
  43. Falsetti P, Acciai C, Lenzi L, Frediani B. Ultrasound of enthesopathy in rheumatic diseases. Mod Rheumatol 2009; 19: 103-13. doi: 10.1007/s10165-008-0129-x
  44. Frediani B, Filippou G, Falsetti P, Lorenzini S, Baldi F, Acciai C, et al. Diagnosis of calcium pyrophosphate dihydrate crystal deposition disease: ultrasonographic criteria proposed. Ann Rheum Dis 2005; 64: 638-40. doi: 10.1136/ ard.2004.024109
  45. Falsetti P, Acciai C, Palilla R, Carpinteri F, Patrizio C, Lenzi L. Bedside ultrasound in early diagnosis of neurogenic heterotopic ossification in patients with acquired brain injury. Clin Neurol Neurosurg 2011; 113: 22-7. doi: 10.1016/j.clineuro.2010.08.012
  46. Stefanidis K, Brindley P, Ramnarine R, Blaivas M, Daneshi M, Sidhu PS, et al. Bedside ultrasound to facilitate early diagnosis and ease of follow-up in neurogenic heterotopic ossification: A pilot study from the intensive care unit. J Head Trauma Rehabil 2017; 32: E54-e8. doi: 10.1097/ HTR.0000000000000293
  47. Wang Q, Zhang P, Li P, Song X, Hu H, Li X, et al. Ultrasonography monitoring of trauma-induced heterotopic ossification: guidance for rehabilitation procedures. Front Neurol 2018; 9: 771. doi: 10.3389/fneur.2018.00771
  48. Amar E, Sharfman ZT, Rath E. Heterotopic ossification after hip arthroscopy. J Hip Preserv Surg 2015; 2: 355-63. doi: 10.1093/jhps/hnv052.
  49. Della Valle AG, Ruzo PS, Pavone V, Tolo E, Mintz DN, Salvati EA. Heterotopic ossification after total hip arthroplasty: a critical analysis of the Brooker classification and proposal of a simplified rating system. J Arthroplasty 2002; 17: 870-5. doi: 10.1054/arth.2002.34819
  50. Schmidt J, Hackenbroch MH. A new classification for heterotopic ossifications in total hip arthroplasty considering the surgical approach. Arch Orthop Trauma Surg 1996; 115: 339-43. doi: 10.1007/BF00420328
  51. Jeon SW, Park YK, Chang SG. Dystrophic calcification and stone formation on the entire bladder neck after potassium-titanyl phosphate laser vaporization for the prostate: a case report. J Korean Med Sci 2009; 24: 741-3. doi: 10.3346/jkms.2009.24.4.741
  52. Tristano AG, Villarroel JL, Rodriguez MA, Millan A. Calcinosis cutis universalis in a patient with systemic lupus erythematosus. Clin Rheumatol 2006; 25: 70-4. doi: 10.1007/s10067-005-1134-5
  53. Hwang Z-A, Suh KJ, Chen D, Chan WP, Wu JS. Imaging features of soft-tissue calcifications and related diseases: a systematic approach. Korean J Radiol 2018; 19: 1147-60. doi: 10.3348/kjr.2018.19.6.1147
  54. Freire V, Moser TP, Lepage-Saucier M. Radiological identification and analysis of soft tissue musculoskeletal calcifications. Insights Imaging 2018; 9: 477-92. doi: 10.1007/s13244-018-0619-0
  55. Ragsdale BD, Madewell JE, Sweet DE. Radiologic and pathologic analysis of solitary bone lesions. Part II: periosteal reactions. Radiol Clin North Am 1981; 19: 749-83.
  56. Miksanek J, Rosenthal AK. Imaging of calcium pyrophosphate deposition disease. Curr Rheumatol Rep 2015; 17: 20. doi: 10.1007/s11926-015-0496-1
  57. Villiaumey J, Avouac B. [Role of radiology in the diagnosis of joint chondro-calcinosis]. [Fench] The so-called atypical symptomatic aspects. J Radiol 1994; 75: 339-61.
  58. Helms C. Fundamentals of Skeletal Radiology 4th Edition. Amsterdam: Elsevier; 2014.
  59. Fathi I, Sakr M. Review of tumoral calcinosis: a rare clinico-pathological entity. World J Clin Cases 2014; 2: 409-14. doi: 10.12998/wjcc.v2.i9.409
  60. Topaz O, Shurman DL, Bergman R, Indelman M, Ratajczak P, Mizrachi M, et al. Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis. Nat Genet 2004; 36: 579-81. doi: 10.1038/ng1358
  61. Benet-Pages A, Orlik P, Strom TM, Lorenz-Depiereux B. An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum Mol Genet 2005; 14: 385-90. doi: 10.1093/hmg/ddi034
  62. Kim H-S, Suh JS, Kim YH, Park S-H. Tumoral calcinosis of the hand: Three unusual cases with painful swelling of small joints. Arch Pathol Lab Med 2006; 130: 548-51. doi: 10.1043/1543-2165(2006)130[548:TCOTHT]2.0. CO;2
  63. Asuncion GF, Tzarnas CD. Uremic tumoral calcinosis: acute hand presentations mimicking infection. J Hand Surg Am 1994; 19: 809-12. doi: 10.1016/0363-5023(94)90190-2
  64. Pakasa NM, Kalengayi RM. Tumoral calcinosis: a clinicopathological study of 111 cases with emphasis on the earliest changes. Histopathology 1997; 31: 18-24. doi: 10.1046/j.1365-2559.1997.6050831.x
  65. Meltzer CC, Fishman EK, Scott WW, Jr. Tumoral calcinosis causing bone erosion in a renal dialysis patient. Clin Imaging 1992; 16: 49-51. doi: 10.1016/0899-7071(92)90091-M
  66. Olsen KM, Chew FS. Tumoral calcinosis: Pearls, polemics, and alternative possibilities. Radiographics 2006; 26: 871-85. doi: 10.1148/rg.263055099
  67. Stevens MA, El-Khoury GY, Kathol MH, Brandser EA, Chow S. Imaging features of avulsion injuries. Radiographics 1999; 19: 655-72. doi: 10.1148/ radiographics.19.3.g99ma05655
  68. Ritter J, Bielack SS. Osteosarcoma. Ann Oncol 2010; 21 (Suppl 7): vii320-5. doi: 10.1093/annonc/mdq276
  69. Bielack S, Jurgens H, Jundt G, Kevric M, Kuhne T, Reichardt P, et al. Osteosarcoma: the COSS experience. Cancer Treat Res 2009; 152: 289-308. doi: 10.1007/978-1-4419-0284-9_15
  70. Park SK, Lee IS, Cho KH, Lee YH, Yi JH, Choi KU. Osteosarcoma of pelvic bones: imaging features. Clin Imaging 2017; 41: 59-64. doi: 10.1016/j. clinimag.2016.10.013
  71. Dosda R, Marti-Bonmati L, Menor F, Aparisi F, Rodrigo C, Ricart V. Comparison of plain radiographs and magnetic resonance images in the evaluation of periosteal reaction and osteoid matrix in osteosarcomas. MAGMA 1999; 9: 72-80. doi: 10.1007/BF02634595
  72. McQueen FM, Doyle A, Dalbeth N. Imaging in gout--what can we learn from MRI, CT, DECT and US? Arthritis Res Ther 2011; 13: 246. doi: 10.1186/ ar34
  73. Barthelemy CR, Nakayama DA, 89. Carrera GF, Lightfoot RW, Jr., Wortmann RL. Gouty arthritis: a prospective radiographic evaluation of sixty patients. Skeletal Radiol 1984; 11: 1-8. doi: 10.1007/BF00361124
  74. Dalbeth N, Clark B, McQueen F, Doyle A, Taylor W. Validation of a radiographic damage index in chronic gout. Arthritis Rheum 2007; 57: 1067-73. doi: 10.1002/art.22891
  75. Girish G, Glazebrook KN, Jacobson JA. Advanced imaging in gout. AJR Am J Roentgenol 2013; 201: 515-25. doi: 10.2214/AJR.13.10776
  76. Oliva F, Via AG, Maffulli N. Physiopathology of intratendinous calcific deposition. BMC Med 2012; 10: 95. doi: 10.1186/1741-7015-10-95
  77. Siegal DS, Wu JS, Newman JS, Del Cura JL, Hochman MG. Calcific tendinitis: a pictorial review. Can Assoc Radiol J 2009; 60: 263-72. doi: 10.1016/j. carj.2009.06.008
  78. Harvie P, Pollard TC, Carr AJ. Calcific tendinitis: natural history and association with endocrine disorders. J Shoulder Elbow Surg 2007; 16: 169-73. doi: 10.1016/j.jse.2006.06.007
  79. Uhthoff HK, Loehr JW. Calcific tendinopathy of the rotator cuff: Pathogenesis, diagnosis, and management. J Am Acad Orthop Surg 1997; 5: 183-91. doi: 10.5435/00124635-199707000-00001
  80. Bazzocchi A, Pelotti P, Serraino S, Battaglia M, Bettelli G, Fusaro I, et al. Ultrasound imaging-guided percutaneous treatment of rotator cuff calcific tendinitis: success in short-term outcome. Br J Radiol 2016; 89: 20150407. doi: 10.1259/bjr.20150407
  81. Norenberg D, Ebersberger HU, Walter T, Ockert B, Knobloch G, Diederichs G, et al. Diagnosis of calcific tendonitis of the rotator Cuff by Using Susceptibility-weighted MR Imaging. Radiology 2016; 278: 475-84. doi: 10.1148/radiol.2015150034
  82. Kaplan FS, Le Merrer M, Glaser DL, Pignolo RJ, Goldsby RE, Kitterman JA, et al. Fibrodysplasia ossificans progressiva. Best Pract Res Clin Rheumatol 2008; 22: 191-205. doi: 10.1016/j.berh.2007.11.007
  83. Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho TJ, Choi IH, et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 2006; 38: 525-7. doi: 10.1038/ng1783
  84. Cohen RB, Hahn GV, Tabas JA, Peeper J, Levitz CL, Sando A, et al. The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. A study of forty-four patients. J Bone Joint Surg Am 1993; 75: 215-9. doi: 10.2106/00004623-199302000-00008
  85. Klang A, Kneissl S, Glanzel R, Fuchs-Baumgartinger A. Imaging diagnosis: fibrodysplasia ossificans progressiva in a cat. Vet Radiol Ultrasound 2013; 54: 532-5. doi: 10.1111/vru.12040
  86. Karunakar MA, Sen A, Bosse MJ, Sims SH, Goulet JA, Kellam JF. Indometacin as prophylaxis for heterotopic ossification after the operative treatment of fractures of the acetabulum. J Bone Joint Surg Br 2006; 88: 1613-7. doi: 10.1302/0301-620X.88B12.18151
  87. Pavlou G, Kyrkos M, Tsialogiannis E, Korres N, Tsiridis E. Pharmacological treatment of heterotopic ossification following hip surgery: an update. Expert Opin Pharmacother 2012; 13: 619-22. doi: 10.1517/14656566.2012.662342
  88. Fransen M, Anderson C, Douglas J, MacMahon S, Neal B, Norton R, et al. Safety and efficacy of routine postoperative ibuprofen for pain and disability related to ectopic bone formation after hip replacement surgery (HIPAID): randomised controlled trial. BMJ 2006; 333: 519. doi: 10.1136/ bmj.38925.471146.4F
  89. Fransen M, Neal B. Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty. Cochrane Database Syst Rev 2004; Cd001160. doi: 10.1002/14651858.CD001160.pub2
  90. Barbato M, D’Angelo E, Di Loreto G, Menna A, Di Francesco A, Salini V, et al. Adherence to routine use of pharmacological prophylaxis of heterotopic ossification after total hip arthroplasty: results from an Italian multicenter, prospective, observational survey. J Orthop Traumatol 2012; 13: 63-7. doi: 10.1007/s10195-012-0180-4
  91. Vuolteenaho K, Moilanen T, Moilanen E. Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing process. Basic Clin Pharmacol Toxicol 2008; 102: 10-4. doi: 10.1111/j.1742-7843.2007.00149.x
  92. Chang JK, Li CJ, Wu SC, Yeh CH, Chen CH, Fu YC, et al. Effects of anti-inflammatory drugs on proliferation, cytotoxicity and osteogenesis in bone marrow mesenchymal stem cells. Biochem Pharmacol 2007; 74: 1371-82. doi: 10.1016/j.bcp.2007.06.047
  93. Sell S, Willms R, Jany R, Esenwein S, Gaissmaier C, Martini F, et al. The suppression of heterotopic ossifications: radiation versus NSAID therapy--a prospective study. J Arthroplasty 1998; 13: 854-9. doi: 10.1016/S0883-5403(98)90189-9
  94. Macfarlane RJ, Ng BH, Gamie Z, El Masry MA, Velonis S, Schizas C, et al. Pharmacological treatment of heterotopic ossification following hip and acetabular surgery. Expert Opin Pharmacother 2008; 9: 767-86. doi: 10.1517/14656566.9.5.767
  95. Coventry MB, Scanlon PW. The use of radiation to discourage ectopic bone. A nine-year study in surgery about the hip. J Bone Joint Surg Am 1981; 63: 201-8. doi: 10.2106/00004623-198163020-00004
  96. Childs HA, 3rd, Cole T, Falkenberg E, Smith JT, Alonso JE, Stannard JP, et al. A prospective evaluation of the timing of postoperative radiotherapy for preventing heterotopic ossification following traumatic acetabular fractures. Int J Radiat Oncol Biol Phy 2000; 47: 1347-52. doi: 10.1016/ S0360-3016(00)00582-4
  97. Chao ST, Lee SY, Borden LS, Joyce MJ, Krebs VE, Suh JH. External beam radiation helps prevent heterotopic bone formation in patients with a history of heterotopic ossification. J Arthroplasty 2006; 21: 731-6. doi: 10.1016/j. arth.2005.08.014
  98. Strauss JB, Chen SS, Shah AP, Coon AB, Dickler A. Cost of radiotherapy versus NSAID administration for prevention of heterotopic ossification after total hip arthroplasty. Int J Radiat Oncol Biol Phy 2008; 71: 1460-4. doi: 10.1016/j.ijrobp.2007.12.006
  99. Vavken P, Castellani L, Sculco TP. Prophylaxis of heterotopic ossification of the hip: systematic review and meta-analysis. Clin Orthop Relat Res 2009; 467: 3283-9. doi: 10.1007/s11999-009-0924-5
  100. Mavrogenis AF, Soucacos PN, Papagelopoulos PJ. Heterotopic ossification revisited. Orthopedics 2011; 34: 177. doi: 10.3928/01477447-20110124-08
  101. Agarwal S, Loder S, Cholok D, Li J, Breuler C, Drake J, et al. Surgical excision of heterotopic ossification leads to re-emergence of mesenchymal stem cell populations responsible for recurrence. Stem Cells Transl Med 2017; 6: 799-806. doi: 10.5966/sctm.2015-0365
DOI: https://doi.org/10.2478/raon-2019-0039 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 275 - 284
Submitted on: Feb 20, 2019
|
Accepted on: Jul 11, 2019
|
Published on: Sep 24, 2019
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 Bilal Mujtaba, Ahmed Taher, Matthew J. Fiala, Sameh Nassar, John E. Madewell, Abdelrahman K. Hanafy, Rizwan Aslam, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.